KD Logo

NKGen Biotech Inc’s latest rating changes from various analysts

In a filing, NKGen Biotech Inc revealed its Chief Executive Officer Song Paul Y. acquired Company’s shares for reported $250.0 on Dec 07 ’23. In the deal valued at $3.29 per share,76 shares were bought. As a result of this transaction, Song Paul Y. now holds 171,121 shares worth roughly $70159.61.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Song Paul Y. bought 75 shares, generating $250 in total proceeds. Upon buying the shares at $3.32, the Chief Executive Officer now owns 171,045 shares.

Before that, Song Paul Y. bought 163 shares. NKGen Biotech Inc shares valued at $500 were divested by the Chief Executive Officer at a price of $3.07 per share. As a result of the transaction, Song Paul Y. now holds 170,864 shares, worth roughly $70054.23999999999.

Price Performance Review of NKGN

On Tuesday, NKGen Biotech Inc [NASDAQ:NKGN] saw its stock fall -8.02% to $0.41. Over the last five days, the stock has gained 80.43%. NKGen Biotech Inc shares have fallen nearly -84.91% since the year began. Nevertheless, the stocks have fallen -86.12% over the past one year. While a 52-week high of $5.10 was reached on 03/06/24, a 52-week low of $0.20 was recorded on 10/15/24. SMA at 50 days reached $0.5859, while 200 days put it at $1.2808.

Levels Of Support And Resistance For NKGN Stock

The 24-hour chart illustrates a support level at 0.3813, which if violated will result in even more drops to 0.3477. On the upside, there is a resistance level at 0.4483. A further resistance level may holdings at 0.4817. The Relative Strength Index (RSI) on the 14-day chart is 48.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0593, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.16%. Stochastics %K at 32.89% indicates the stock is a holding.

How much short interest is there in NKGen Biotech Inc?

A steep rise in short interest was recorded in NKGen Biotech Inc stocks on 2024-09-30, dropping by -0.24 million shares to a total of 0.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 0.64 million shares. There was a decline of -61.43%, which implies that there is a negative sentiment for the stock.

Most Popular